“multiple-sclerosis” Archives

in
Entry Author Date Location
MS Drug Patent Rulings Give Biogen Win, Acorda Loss in Separate Suits 03/31/17 Boston
Bio Roundup: New Drug Bonanza, Vertex’s Triple Play, CAR-T Race & More 03/31/17 National
With FDA Approval, Genentech Drug Becomes First For Severe MS Cases 03/29/17 San Francisco
Gener8tor, ParqEx, 4490, RPRD, & More: This Week’s WI Watchlist 02/21/17 Wisconsin
Bio Roundup: CRISPR Drama, Marathon and PhRMA, the Price of Vision & More 02/17/17 National
Better Together, or Apart? Biogen, Bioverativ Head Down Separate Paths 02/01/17 Boston
14 for ’17: Key Clinical Data To Watch For Next Year (Part 2) 12/22/16 National
Despite FDA Delay, Advocates Hopeful for New Genentech MS Drug 12/21/16 San Francisco
Biogen Promotes Vounatsos to CEO, Capping Scangos’s 6-Year Run 12/19/16 Boston
Bio Roundup: CAR-T & Migraine Races, Intra-Cellular, Rockefeller & More 09/30/16 National
With Biogen at a Crossroads, CEO Scangos to Step Down 07/21/16 Boston
Merck, Amgen Invest in Akili as Therapeutic Video Game Moves Ahead 07/20/16 Boston
Harvard’s Springer Gets $51.5M From Pharmas, Others, For Latest Startup 06/30/16 Boston
Biotech Roundup: ASCO, BIO, Drug Setbacks, Incubators & More 06/10/16 National
Biogen’s Nerve Repair Drug Fails MS Study, Shares Fall 06/07/16 Boston
Arbor Pharma Pays $467M for Struggling XenoPort, Restless Legs Drug 05/23/16 San Francisco
Biogen Turns To UPenn Gene Therapy Pioneers in Wide-Ranging Alliance 05/16/16 Boston
Biogen’s Scangos on Pricing, Deals, Hemophilia, Alzheimer’s & More 02/09/16 Boston
Biogen, Arsia Team Up to Improve Hemophilia Drugs in $100M Pact 12/16/15 Boston
In New York and Montreal, Versant Seeds Two New Biotech Startups 12/10/15 New York
NY Stem Cell Foundation Grows, Eyes Forming Big Apple Bio Incubator 12/03/15 New York
Biogen to Cut 400 Jobs in Massachusetts in Big Restructuring 10/21/15 Boston
Pharma Plays The “Value” Card: Drug Spending Then And Now 09/14/15 National
East Coast Biotech Roundup: Biogen, Watson, Data Dumps & More 09/11/15 Boston
Biogen Pays $60M to Take on Celgene With a Rival Autoimmune Drug 09/09/15 Boston
East Coast Biotech Roundup: Celgene, Chiasma, Cerulean, & More 07/17/15 Boston
Orphan Drug Maker Chiasma Raises $101.8M in IPO 07/16/15 Boston
Biogen R&D Chief Doug Williams Leaves to Run New Cancer Startup 07/10/15 Boston
23andMe Pharma? That’s the Plan, Says the Genetic Test Maker 03/12/15 San Francisco
RayVio Absorbs $9.3M for UV Technology to Clean Water and Air 03/10/15 San Francisco
Page 1 of 8 next page »